Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
Delayed Quote. Delayed Nasdaq - 10/27 04:00:00 pm
321.74 USD   +0.84%
10/26ILLUMINA, INC. : quaterly earnings release
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The group usually releases upbeat results with huge surprise rates.
Weaknesses
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 87.42 and 51.83 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
ILLUMINA, INC.-3.01%47 090
THERMO FISHER SCIENTIFIC50.61%190 844
DANAHER CORPORATION56.23%166 875
INTUITIVE SURGICAL, INC.21.95%83 672
SHENZHEN MINDRAY BIO-MEDICA..99.41%65 748
BOSTON SCIENTIFIC CORPORATI..-20.28%52 735
EDWARDS LIFESCIENCES CORPOR..-1.62%48 546
SIEMENS HEALTHINEERS AG-12.07%47 672
KONINKLIJKE PHILIPS N.V.-2.18%44 334
AGILENT TECHNOLOGIES, INC.24.30%32 258
RESMED, INC.19.28%26 160
OLYMPUS CORPORATION16.99%24 395
CERNER CORPORATION-0.89%22 253
HOLOGIC, INC.35.84%17 782
VARIAN MEDICAL SYSTEMS, INC..21.79%15 722
PERKINELMER, INC.30.88%13 873
More Results
Financials (USD)
Sales 2020 3 095 M - -
Net income 2020 550 M - -
Net cash 2020 2 068 M - -
P/E ratio 2020 87,4x
Yield 2020 -
Capitalization 47 090 M 47 090 M -
EV / Sales 2020 14,5x
EV / Sales 2021 11,7x
Nbr of Employees 7 700
Free-Float 75,1%
Upcoming event on ILLUMINA, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes